Abstract
A novel iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, and desferrioxamine were compared for their ability to remove iron and for their site of action in iron release in rats. Repeated intraperitoneal injections of the chelators in rats with widespread tissue labelling by 59Fe derived from transferrin showed comparable 59Fe mobilisation by each chelator in normal and iron loaded rats. Specific labelling of a chelatable "cold" iron pool in hepatocytes by 59Fe derived from ferritin showed this pool to be equally accessible to parenteral doses of both chelators and also to oral 1,2-dimethyl-3-hydroxypyrid-4-one, which is an effective oral iron chelating agent that removes iron from parenchymal cells. This and other alpha-ketohydroxypyridines need further development as potential therapeutic agents in human iron overload.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hershko C., Cook J. D., Finch D. A. Storage iron kinetics. 3. Study of desferrioxamine action by selective radioiron labels of RE and parenchymal cells. J Lab Clin Med. 1973 Jun;81(6):876–886. [PubMed] [Google Scholar]
- KALDOR I. Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron. Aust J Exp Biol Med Sci. 1954 Dec;32(6):795–799. doi: 10.1038/icb.1954.82. [DOI] [PubMed] [Google Scholar]
- Kontoghiorghes G. J. Dose response studies using desferrioxamine and orally active chelators in a mouse model. Scand J Haematol. 1986 Jul;37(1):63–70. doi: 10.1111/j.1600-0609.1986.tb01773.x. [DOI] [PubMed] [Google Scholar]
- Kontoghiorghes G. J., Hoffbrand A. V. Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol. 1986 Apr;62(4):607–613. doi: 10.1111/j.1365-2141.1986.tb04082.x. [DOI] [PubMed] [Google Scholar]
- Kontoghiorghes G. J. Iron mobilization from ferritin using alpha-oxohydroxy heteroaromatic chelators. Biochem J. 1986 Jan 1;233(1):299–302. doi: 10.1042/bj2330299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kontoghiorghes G. J. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice. Mol Pharmacol. 1986 Dec;30(6):670–673. [PubMed] [Google Scholar]
- Kontoghiorghes G. J. The study of iron mobilisation from transferrin using alpha-ketohydroxy heteroaromatic chelators. Biochim Biophys Acta. 1986 Jan 30;869(2):141–146. doi: 10.1016/0167-4838(86)90288-8. [DOI] [PubMed] [Google Scholar]
- Wolfe L., Olivieri N., Sallan D., Colan S., Rose V., Propper R., Freedman M. H., Nathan D. G. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med. 1985 Jun 20;312(25):1600–1603. doi: 10.1056/NEJM198506203122503. [DOI] [PubMed] [Google Scholar]